BioLife Sets October 5 Vote on $1.5B Repligen Merger; $59M Termination Fee Disclosed
BLFS sits 97% above its 52-week low of $17.86 on light trading volume (0.3× avg).
Summary
BioLife Solutions filed its definitive proxy for the Repligen merger, scheduling a stockholder vote for October 5, 2026. The filing discloses a $59M termination fee, executive golden parachutes, and confirms the $31.00 per share consideration.
Key Events · M&A and Partnerships · BLFS
-
Special Meeting Set for October 5
Stockholders of record as of September 3, 2026 (48,923,333 shares outstanding) will vote on the Repligen merger at a virtual special meeting on October 5, 2026.
-
Merger Consideration Confirmed
Each BioLife share converts to $11.25 cash plus 0.1442 Repligen shares. At Repligen's September 2, 2026 close of $172.94, the implied value is $36.19 per BioLife share — above the $31.00 deal price at announcement.
-
$59M Termination Fee
BioLife must pay Repligen $59 million if the deal terminates under specified circumstances, including a superior proposal or change of board recommendation.
-
Executive Golden Parachutes
CEO Roderick de Greef could receive $28.9 million in merger-related compensation, including $26.1 million in accelerated equity. Total for all five named executive officers is approximately $52.2 million.
Analysis · BLFS · Industrial Applications And Services
The definitive proxy statement advances the Repligen acquisition from announcement to actionable vote. Stockholders of record as of September 3, 2026 will vote October 5, 2026 on the $31.00 per share deal ($11.25 cash plus 0.1442 Repligen shares). The filing reveals a $59 million termination fee, Centerview's fairness opinion supporting the price, and golden parachute compensation totaling $28.9 million for CEO Roderick de Greef alone. The HSR waiting period expires September 3, 2026, clearing a key regulatory hurdle. With the implied merger value now $36.19 per share versus the $31.00 deal price, the fixed exchange ratio means BioLife holders capture Repligen's stock appreciation — a meaningful premium to the original announcement.
How filings like this one have moved
In the 30 days to Sep 9, 2026, 36.4% of the 1919 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BLFS was trading at $35.25 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $17.86 to $38.10. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.